{"database": "lobbying", "table": "lobbying_activities", "rows": [[2340729, "76a93f52-083a-4179-b67b-2b1800632c31", "Q3", "NATIONAL KIDNEY FOUNDATION", 28105, "NATIONAL KIDNEY FOUNDATION", 2019, "third_quarter", "MMM", "Early detection and management of Chronic Kidney Disease, including Alternative Payment Model\n\nIncreased utilization of home dialysis\n\nExtension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients\n\nIncreased use of Kidney Discards for transplantation\n\nAccess of medications under Medicare Part D Protected Classes \n\nComments on proposed rule on ESRD Treatment Choices Model\n\nComments on ESRD Prospective Payment System and Quality Incentive Program\n\nComments on interpretive guidance Conditions of Participation for organ transplant programs\n\nComments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 100000, 0, 0, "2019-10-11T14:22:49.063000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2340729"], "units": {}, "query_ms": 8.220866962801665, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}